Expression of hexokinase isoforms in the dorsal root ganglion of the adult rat and effect of experimental diabetes

Brain Research

Volumn 1175, Issue 1, 2007, Pages 143-154

  Gardiner, Natalie J ^a   Wang, Zuocheng ^c   Luke, Claire ^a   Gott, Angela ^a   Price, Sally A ^a   Fernyhough, Paul ^a,b,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Diabetes; Glycolysis; Insulin; Mitochondria; Neuropathy; Satellite cell

Indexed keywords

HEXOKINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CELL CULTURE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOLYSIS; HOMOGENATE; IMMUNOFLUORESCENCE TEST; MALE; MITOCHONDRION; NERVE CELL; NERVE FIBER TRANSPORT; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SATELLITE CELL; SCIATIC NERVE; SENSORY NERVE CELL; SPINAL GANGLION; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; AXONAL TRANSPORT; CELL SIZE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FLUORESCENT ANTIBODY TECHNIQUE; GANGLIA, SPINAL; GLUCOSE; GLYCOLYSIS; HEXOKINASE; ISOENZYMES; MALE; MECHANORECEPTORS; MITOCHONDRIA; NEURONS, AFFERENT; NOCICEPTORS; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 34948884055     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.08.015     Document Type: Article

References (63)

1. Averill S., Davis D.R., Shortland P.J., Priestley J.V., and Hunt S.P. Dynamic pattern of reg-2 expression in rat sensory neurons after peripheral nerve injury. J. Neurosci. 22 (2002) 7493-7501
2. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 (2002) 636-640
3. da-Silva W.S., Gomez-Puyou A., de Gomez-Puyou M.T., Moreno-Sanchez R., De Felice F.G., de Meis L., Oliveira M.F., and Galina A. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. J. Biol. Chem. 279 (2004) 39846-39855
4. D.C.C.T. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group. Diabetes Care 13 (1990) 427-433
5. de Cerqueira Cesar M., and Wilson J.E. Application of a double isotopic labeling method to a study of the interaction of mitochondrially bound rat brain hexokinase with intramitochondrial compartments of ATP generated by oxidative phosphorylation. Arch. Biochem. Biophys. 324 (1995) 9-14
6. Delcroix J.D., Averill S., Fernandes K., Tomlinson D.R., Priestley J.V., and Fernyhough P. Axonal transport of activating transcription factor-2 is modulated by nerve growth factor in nociceptive neurons. J. Neurosci. 19 (1999) RC24
7. Fernyhough P., Willars G.B., Lindsay R.M., and Tomlinson D.R. Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain Res. 607 (1993) 117-124
8. Fernyhough P., Huang T.J., and Verkhratsky A. Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J. Peripher. Nerv. Syst. 8 (2003) 227-235
9. Gardiner N.J., Fernyhough P., Tomlinson D.R., Mayer U., von der Mark H., and Streuli C.H. Alpha7 integrin mediates neurite outgrowth of distinct populations of adult sensory neurons. Mol. Cell. Neurosci. 28 (2005) 229-240
10. Gottlieb E., Armour S.M., and Thompson C.B. Mitochondrial respiratory control is lost during growth factor deprivation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12801-12806
11. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R.B., and Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15 (2001) 1406-1418
12. Halder J., Ray M., and Ray S. Inhibition of glycolysis and mitochondrial respiration of Ehrlich ascites carcinoma cells by methylglyoxal. Int. J. Cancer 54 (1993) 443-449
13. Hammerman P.S., Fox C.J., and Thompson C.B. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem. Sci. 29 (2004) 586-592
14. Henningsen C., Zahner G., and Thaiss F. High glucose induces type 1 hexokinase gene expression in isolated glomeruli of diabetic rats and in mesangial cells. Nephron. Physiol. 93 (2003) 67-75
15. Ho E.C., Lam K.S., Chen Y.S., Yip J.C., Arvindakshan M., Yamagishi S., Yagihashi S., Oates P.J., Ellery C.A., Chung S.S., and Chung S.K. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55 (2006) 1946-1953
16. Huang T.J., Price S.A., Chilton L., Calcutt N.A., Tomlinson D.R., Verkhratsky A., and Fernyhough P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52 (2003) 2129-2136
17. Huang T.J., Sayers N.M., Verkhratsky A., and Fernyhough P. Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp. Neurol. 194 (2005) 279-283
18. Huang T.J., Verkhratsky A., and Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol. Cell. Neurosci. 28 (2005) 42-54
19. Jacobsson G., and Meister B. Hexokinase I messenger RNA in the rat central nervous system. Mol. Cell. Neurosci. 5 (1994) 658-677
20. Jiang Y., Calcutt N.A., Rames K.M., and Mizisin A.P. Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. J. Peripher. Nerv. Syst. 11 (2006) 274-285
21. Kabir F., and Wilson J.E. Mitochondrial hexokinase in brain of various species: differences in sensitivity to solubilization by glucose 6-phosphate. Arch. Biochem. Biophys. 300 (1993) 641-650
22. Karachalias N., Babaei-Jadidi R., Ahmed N., and Thornalley P.J. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem. Soc. Trans. 31 (2003) 1423-1425
23. Kishi Y., Schmelzer J.D., Yao J.K., Zollman P.J., Nickander K.K., Tritschler H.J., and Low P.A. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 48 (1999) 2045-2051
24. Lindsay R.M. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J. Neurosci. 8 (1988) 2394-2405
25. Llewelyn J.G., Thomas P.K., and Mirrlees D.J. Aldose reductase activity and myo-inositol levels in sciatic nerve and dorsal root ganglia of the diabetic mutant mouse [C57/BL/Ks (db/db)]. Metabolism 40 (1991) 1084-1087
26. Majewski N., Nogueira V., Bhaskar P., Coy P.E., Skeen J.E., Gottlob K., Chandel N.S., Thompson C.B., Robey R.B., and Hay N. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 16 (2004) 819-830
27. Majewski N., Nogueira V., Robey R.B., and Hay N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol. 24 (2004) 730-740
28. Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Siddique I., Sharma A.K., Boulton A.J., King R.H., Thomas P.K., and Ward J.D. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48 (2005) 578-585
29. Medori R., Autilio-Gambetti L., Monaco S., and Gambetti P. Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 7716-7720
30. Medori R., Jenich H., Autilio-Gambetti L., and Gambetti P. Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models. J. Neurosci. 8 (1988) 1814-1821
31. Miwa I., Adachi K., Murase S., Hamada Y., and Sugiura M. 4-Hydroxy-2-nonenal hardly affects glycolysis. Free Radic. Biol. Med. 23 (1997) 610-615
32. Mizisin A.P., Calcutt N.A., Tomlinson D.R., Gallagher A., and Fernyhough P. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats. J. Peripher. Nerv. Syst. 4 (1999) 211-221
33. Muller G., Korndorfer A., Kornak U., and Malaisse W.J. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride. Arch. Biochem. Biophys. 308 (1994) 8-23
34. Nishikawa T., Edelstein D., and Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Inter., Suppl. 77 (2000) S26-S30
35. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
36. Novotny M.V., Yancey M.F., Stuart R., Wiesler D., and Peterson R.G. Inhibition of glycolytic enzymes by endogenous aldehydes: a possible relation to diabetic neuropathies. Biochim. Biophys. Acta 1226 (1994) 145-150
37. Obrosova I., Faller A., Burgan J., Ostrow E., and Williamson J.R. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor. Curr. Eye Res. 16 (1997) 34-43
38. Obrosova I.G., Pacher P., Szabo C., Zsengeller Z., Hirooka H., Stevens M.J., and Yorek M.A. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54 (2005) 234-242
39. Ola M.S., Berkich D.A., Xu Y., King M.T., Gardner T.W., Simpson I., and LaNoue K.F. Analysis of glucose metabolism in diabetic rat retinas. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1057-E1067
40. Pastorino J.G., Shulga N., and Hoek J.B. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 277 (2002) 7610-7618
41. Patel J., and Tomlinson D.R. Nerve conduction impairment in experimental diabetes-proximodistal gradient of severity. Muscle Nerve 22 (1999) 1403-1411
42. Pfeiffer-Guglielmi B., Fleckenstein B., Jung G., and Hamprecht B. Immunocytochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies. J. Neurochem. 85 (2003) 73-81
43. Pfeiffer-Guglielmi B., Francke M., Reichenbach A., and Hamprecht B. Glycogen phosphorylase isozymes and energy metabolism in the rat peripheral nervous system-an immunocytochemical study. Brain Res. 1136 (2007) 20-27
44. Polakis P.G., and Wilson J.E. An intact hydrophobic N-terminal sequence is critical for binding of rat brain hexokinase to mitochondria. Arch. Biochem. Biophys. 236 (1985) 328-337
45. Powell C.S., and Jackson R.M. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD. Am. J. Physiol., Lung Cell. Mol. Physiol. 285 (2003) L189-L198
46. Ramer M.S., Bradbury E.J., Michael G.J., Lever I.J., and McMahon S.B. Glial cell line-derived neurotrophic factor increases calcitonin gene-related peptide immunoreactivity in sensory and motoneurons in vivo. Eur. J. Neurosci. 18 (2003) 2713-2721
47. Robey R.B., and Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25 (2006) 4683-4696
48. Robey R.B., Raval B.J., Ma J., and Santos A.V. Thrombin is a novel regulator of hexokinase activity in mesangial cells. Kidney Int. 57 (2000) 2308-2318
49. Roncero I., Alvarez E., Vazquez P., and Blazquez E. Functional glucokinase isoforms are expressed in rat brain. J. Neurochem. 74 (2000) 1848-1857
50. Rose R.D., and Rohrlich D. Counting sectioned cells via mathematical reconstruction. J. Comp. Neurol. 272 (1988) 365-386
51. Schwartz J.P., Pearson J., and Johnson E.M. Effect of exposure to anti-NGF on sensory neurons of adult rats and guinea pigs. Brain Res. 244 (1982) 378-381
52. Sima A.A., and Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia 42 (1999) 773-788
53. Srinivasan S., Stevens M., and Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49 (2000) 1932-1938
54. Stanley W.C., Lopaschuk G.D., and McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res. 34 (1997) 25-33
55. Trueblood N., and Ramasamy R. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am. J. Physiol. 275 (1998) H75-H83
56. Uehara K., Yamagishi S., Otsuki S., Chin S., and Yagihashi S. Effects of polyol pathway hyperactivity on protein kinase C activity, nociceptive peptide expression, and neuronal structure in dorsal root ganglia in diabetic mice. Diabetes 53 (2004) 3239-3247
57. Whitesell R.R., Ward M., McCall A.L., Granner D.K., and May J.M. Coupled glucose transport and metabolism in cultured neuronal cells: determination of the rate-limiting step. J. Cereb. Blood Flow Metab. 15 (1995) 814-826
58. Wilkin G.P., and Wilson J.E. Localization of hexokinase in neural tissue: light microscopic studies with immunofluorescence and histochemical procedures. J. Neurochem. 29 (1977) 1039-1051
59. Wilson J.E., and Chung V. Rat brain hexokinase: further studies on the specificity of the hexose and hexose 6-phosphate binding sites. Arch. Biochem. Biophys. 269 (1989) 517-525
60. Wilson J.E. Hexokinases. Rev. Physiol., Biochem. Pharmacol. 126 (1995) 65-198
61. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 206 (2003) 2049-2057
62. Yagihashi S. Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models. J. Peripher. Nerv. Syst. 2 (1997) 113-132
63. Ye G., Donthi R.V., Metreveli N.S., and Epstein P.N. Overexpression of hexokinase protects hypoxic and diabetic cardiomyocytes by increasing ATP generation. Cardiovasc. Toxicol. 5 (2005) 293-300